The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
K Heshmat-Ghahdarijani, V Sarmadi, A Heidari… - Frontiers in …, 2023 - frontiersin.org
The increasing incidence of cancer globally has highlighted the significance of early
diagnosis and improvement of treatment strategies. In the 19th century, a connection was …
diagnosis and improvement of treatment strategies. In the 19th century, a connection was …
The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
S Tiainen, K Rilla, K Hämäläinen, S Oikari… - Breast cancer research …, 2021 - Springer
Purpose The aim of this study was to investigate the prognostic impact of two systemic
inflammatory markers, the neutrophil-to-lymphocyte ratio (NLR) and the monocyte-to …
inflammatory markers, the neutrophil-to-lymphocyte ratio (NLR) and the monocyte-to …
Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy
J Pang, N Ding, N Yin, Z Xiao - Scientific Reports, 2024 - nature.com
The prognostic value of SII (Systemic Immune-Inflammation Index) in HER-2-positive breast
cancer (BC) patients, regardless of whether they receive trastuzumab treatment, and its …
cancer (BC) patients, regardless of whether they receive trastuzumab treatment, and its …
Relationship between the neutrophil to lymphocyte ratio, stromal tumor-infiltrating lymphocytes, and the prognosis and response to neoadjuvant chemotherapy in triple …
J Pang, H Zhou, X Dong, S Wang, Z Xiao - Clinical Breast Cancer, 2021 - Elsevier
Introduction Neutrophil to lymphocyte ratio (NLR) and stromal tumor-infiltrating lymphocytes
(sTILs) are correlated with triple-negative breast cancer (TNBC) patient prognosis. However …
(sTILs) are correlated with triple-negative breast cancer (TNBC) patient prognosis. However …
Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial
N Ding, J Pang, X Liu, X He, W Zhou, H Xie… - Breast Cancer …, 2024 - Springer
Purpose This study aimed to evaluate the prognostic role of the baseline
neutrophil/lymphocyte ratio (NLR) in HER2-positive metastatic breast cancer (MBC) patients …
neutrophil/lymphocyte ratio (NLR) in HER2-positive metastatic breast cancer (MBC) patients …
Novel prognostic biomarkers in gastric cancer: CGB5, MKNK2, and PAPPA2
M Qin, Z Liang, H Qin, Y Huo, Q Wu, H Yang… - Frontiers in …, 2021 - frontiersin.org
Introduction Gastric cancer is one of the most common malignant tumors of the digestive
tract. However, there are no adequate prognostic markers available for this disease. The …
tract. However, there are no adequate prognostic markers available for this disease. The …
An applicable inflammation-joined and nutrition-related prognostic indicator in patients with colorectal cancer
Purpose This study aimed to elucidate the prognostic significance of a novel inflammation-
joined and nutrition-related clinicopathological marker for colorectal cancer (CRC). Methods …
joined and nutrition-related clinicopathological marker for colorectal cancer (CRC). Methods …
[HTML][HTML] Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study
L Hao, J Dong, H Yu, J Chen, X Han… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
Background Peripheral blood biomarkers have been reported to be associated with the
prognosis of breast cancer (BC) patients, but a few findings remain controversial. This study …
prognosis of breast cancer (BC) patients, but a few findings remain controversial. This study …
Associação entre câncer de mama e obesidade, e influência de dois biomarcadores inflamatórios no prognóstico de câncer de mama nesta população, a relação …
LF Orlandini - 2021 - teses.usp.br
Obesidade tem sido associada a um aumento de risco para desenvolvimento de câncer de
mama, além de maior recorrência e mortalidade por esta neoplasia. Alguns biomarcadores …
mama, além de maior recorrência e mortalidade por esta neoplasia. Alguns biomarcadores …
[HTML][HTML] HER2 阳性乳腺癌新辅助化疗联合双靶疗效的列线图预测模型建立
陈东旭， 李金洋， 丰竹慧， 吴琍 - Advances in Clinical Medicine, 2024 - hanspub.org
目的: 研究HER2 阳性乳腺癌接受新辅助化疗联合双靶治疗疗效的相关影响因素,
同时建立预测模型, 旨在提高患者新辅助治疗疗效预测的有效性和准确性 …
同时建立预测模型, 旨在提高患者新辅助治疗疗效预测的有效性和准确性 …